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OBJECTIVES We sought to examine associations between the augmentation index (AI) and metabolic,
adiposity, and lifestyle factors, independent of genetic influences, and to determine whether
gene-environment interactions modulate these relationships.
BACKGROUND Reported associations between AI, an index of systemic arterial stiffness, and metabolic,
adiposity, and lifestyle factors remain contradictory. The modulating effect of genetic risk is
unknown.
METHODS We studied 684 female twins (age 18 to 71 years); AI was derived from the pressure waveform
measured at the radial artery by applanation tonometry. Percentage of total body fat (TBF)
and percentage of central abdominal fat (CAF) were assessed by dual-energy X-ray
absorptiometry.
RESULTS In univariate analysis, age-adjusted AI was significantly associated with fasting triglyceride
levels (r  0.1, p  0.03), apolipoprotein-B/A1 (r  0.1, p  0.04), percentage of TBF (r
 0.11, p  0.006), and percentage of CAF (r  0.11, p  0.004). In co-twin case-control
(monozygotic twin) analysis, a 3.1% absolute within-pair difference in percentage of CAF
accounted for a 6% within-pair difference in AI, independent of genetic effects. Smokers and
subjects with alcohol intakes 15 U/week had higher AI than nonsmokers (p  0.01) and
nondrinkers (p  0.02), respectively. Forty percent of the variance in AI was explained by age,
central mean arterial pressure, heart rate, height, percentage of CAF, and smoking. In
gene-environment interaction analysis, subjects at high genetic risk of increased AI participating
in regular leisure-time physical activity had AI values similar to low genetic risk subjects.
CONCLUSIONS Central abdominal adiposity is a significant determinant of AI in female twins, independent
of hemodynamic, lifestyle, and, importantly, genetic effects. Smoking is associated with
increased AI, even after controlling for abdominal obesity and other AI determinants.
Physical activity reduces genetic predisposition to increased AI. (J Am Coll Cardiol 2003;
42:264–70) © 2003 by the American College of Cardiology Foundation
Central arterial stiffness predicts cardiovascular mortality,
independent of traditional cardiovascular risk factors (1,2).
With age, arterial stiffening increases pulse wave velocity,
resulting in premature reflection of the central systolic
pressure wave (3). Reflection in late systole (rather than in
diastole) “augments” central systolic arterial pressure, re-
duces diastolic coronary perfusion, and increases cardiac
workload (3). The degree of augmentation, expressed as the
“augmentation index” (AI), is derived noninvasively by
applanation tonometry of the radial, carotid, or femoral
arteries and yields information on systemic arterial stiffness
(4–6). Augmentation index is an important marker of
coronary risk (7,8) and independently predicts total and
cardiovascular mortality in end-stage renal failure (1).
Although 18% to 37% of the population variance in AI is
heritable (9,10), several determinants of AI have been
reported, including age (4,6,9,11,12), gender (1,6,7,11),
blood pressure (BP) (6,7,9,11), heart rate (6,7,9,11,13),
height (6,9,11), and type 2 diabetes (13). Augmentation
index has also been associated with abdominal obesity, albeit
estimated anthropometrically (14,15). To our knowledge,
the relationship between directly measured central abdom-
inal fat (CAF) (by dual-energy X-ray absorptiometry
[DXA]) and AI has not been reported. Such a relationship
may mediate, at least partly, the increased cardiovascular
risk associated with the “Metabolic Syndrome” and type 2
diabetes.
No previous study has assessed the effect of lifestyle and
physical factors on AI independent of genetic influences,
important confounders that can only be controlled for by
studying twins. Furthermore, whether individuals geneti-
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cally predisposed to arterial stiffness are more susceptible to
the effects of physical, lifestyle, or metabolic factors has not
been previously examined. Such gene-environment interac-
tions may play an important role in altering phenotypic
expression in genetically predisposed individuals. The twin
model specifically allows examination of the influence of
individual environmental factors, independent of genetic
effects, and permits investigation of gene-environment in-
teractions.
In a large cohort of healthy, pre- and postmenopausal
female twins, we examined associations between AI and
total and central abdominal adiposity, lipid and glycemic
parameters, and lifestyle factors (smoking, alcohol con-
sumption, physical activity, and hormone replacement ther-
apy [HRT]). Studying twins also enabled us to quantify the
contribution of these factors to AI independent of genetic
influences and to investigate the modulating effect of genetic
risk on these relationships.
METHODS
Subject characteristics. The study group comprised 684
healthy Caucasian female twins (53 monozygotic [MZ] and
262 dizygotic [DZ] pairs and 54 singletons [whose co-twin
was excluded or had incomplete data]) recruited from the
general population through media advertisements (via the
St. Thomas’ U.K. Adult Twin Registry) (9). Ischemic heart
disease, stroke, diabetes mellitus, and treatment with lipid-
lowering or antihypertensive medications were exclusion
criteria. Subjects were included in the study if their fasting
plasma glucose level was 6.1 mmol/l, and, in subjects who
had a 75 g oral glucose tolerance test (n  467), 2-h plasma
glucose levels were 7.8 mmol/l. The study was approved
by institutional ethics committees at St. Thomas’ Hospital,
London, UK (phenotypic data collection) and St. Vincent’s
Hospital, Sydney, Australia (data validation, analysis, and
interpretation). All participants provided written informed
consent. Zygosity was ascertained through questionnaire
(16), confirmed by multiplex deoxyribonucleic acid finger-
printing (PE Applied Biosystems, Foster City, California) if
uncertain. Menopause was defined as amenorrhea for 12
months in women 40 years of age. Information on
medication use, lifestyle, and demographic characteristics
were ascertained by standardized questionnaires. Subjects
were categorized as current smokers, ex-smokers, or lifetime
nonsmokers. Subjects reported participation in regular
leisure-time physical activity and time spent in weight-
bearing and non–weight-bearing sports of moderate and
vigorous intensity (17,18). Alcohol intake was recorded as
never (6%), social (28%), 1 to 5 (32%), 6 to 10 (16%), 11 to
15 (8%), 16 to 20 (5%), 21 to 40 (4%), and 40 (1%)
U/week (1 U  8 g of alcohol). As only five subjects were
in the latter category, data on this group was not reported.
Hemodynamic indexes. Brachial BP was measured twice
using an automated cuff sphygmomanometer (OMRON
HEM713C, Tokyo, Japan). Radial artery pressure wave-
forms were measured supine by applanation tonometry
(9,19) and were analyzed using commercially available
software (SphygomoCor, AtCor Medical, Sydney, Austra-
lia). Pressure was applied to the radial artery by a probe
containing a high-fidelity transducer, through which pres-
sure waves were recorded (4,5,9). This technique provides
intra-arterial pressure measurements similar to those ob-
tained invasively (5). An aortic pressure waveform was
generated from peripheral waveforms using a validated
transfer function (20,21). Augmentation index was calcu-
lated by dividing the pressure difference between the second
systolic peak and the diastolic pressure by the difference
between the first systolic peak and the diastolic pressure
(100%) (Fig. 1) (6). As previously described, intra-
operator and inter-operator reproducibility (expressed as
intra-class correlations) were 0.82 and 0.84, respectively (9).
Anthropometry and body composition. Weight (kg) was
measured with subjects in light street clothing and height
(m) by stadiometer. Body mass index (BMI) was calculated
(kg/m2). Waist circumference was measured as the narrow-
est circumference between the lower rib margin and anterior
superior iliac spines. Dual-energy X-ray absorptiometry
(Lunar DPXL, Madison, Wisconsin) was used to measure
total body fat (TBF) and CAF (in kg and %) (18); CAF was
defined as the adipose tissue content of a window bordered
by the upper margin of the second and lower margin of the
fourth lumbar vertebral bodies and the inner aspect of the
ribs (by a single observer) (18).
Biochemical analysis. Fasting plasma glucose was mea-
sured by a glucose-oxidase method and fasting plasma
insulin by radioimmunoassay (Immunodiagnostics Enzum
Test, Boehringer Mannheim, Germany) (n  558). Insulin
resistance (R’) and insulin secretion (’) were estimated by
modified homeostasis model assessment (HOMA) (22).
Fasting lipid and lipoprotein levels were measured in 579
subjects as previously described (23).
Statistical methods. Data are mean  SEM unless other-
wise stated. The generalized estimating equation was used
to correct for intra-pair phenotypic correlations, as standard
statistical analysis of paired data may underestimate stan-
dard errors and overestimate p values (24). Fasting triglyc-
eride and insulin data was loge-transformed to normalize its
distribution. Due to the strong relationship between AI and
Abbreviations and Acronyms
AI  augmentation index
BMI  body mass index
BP  blood pressure
CAF  central abdominal fat
CMAP  central mean arterial pressure
DXA  dual-energy X-ray absorptiometry
DZ  dizygotic
HOMA  homeostasis model assessment
HRT  hormone replacement therapy
MZ  monozygotic
TBF  total body fat
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age (r  0.43, p  0.001), AI was age-adjusted in all
analyses by calculating age-residuals or by including age as a
covariate in analysis of covariance. Stepwise multiple regres-
sion models were constructed (correcting for intra-pair
correlations using the generalized estimating equation) with
AI as the dependent variable and significant factors in
univariate analyses as independent variables. A value of p 
0.05 was considered significant. Data were analyzed by
Statview 5 (SAS Institute Inc., Cary, North Carolina) and
STATA Statistical Software, release 7.0 (StataCorp, Col-
lege Station, Texas).
Co-twin case-control (MZ twin) analysis is a unique and
established model by which the effect of environmental and
physical factors on a measured trait can be quantified
independent of genetic influences (18,25). As MZ twins
have 100% genetic concordance, this model allows poten-
tially confounding genetic factors to be controlled for.
Therefore, any differences within MZ twin pairs for a
measured variable must be due to the environmental or
physical factors for which the twin pairs are discordant. For
example, if MZ twin pairs discordant for a measure of
adiposity have greater within-pair differences in AI than
concordant pairs, adiposity has an effect on AI independent
of genetic influences.
In the current study, we used the co-twin case-control
study design to examine the contribution of body fat
distribution and lifestyle factors (smoking and alcohol in-
take) to AI, independent of genetic effects. Only factors
significantly associated with AI in univariate analysis were
examined in MZ models. Within-pair differences in MZ
pairs discordant for these factors were compared to concor-
dant twin pairs using the Mann-Whitney U test.
Gene-environment interaction analysis was undertaken
to investigate whether univariate associations between en-
vironmental factors and AI were modulated by genetic
susceptibility to increased AI (18,25). The method used was
as follows: MZ and DZ twins were grouped into tertiles of
age-adjusted AI. Genetic risk of increased AI was assigned
to a randomly selected twin from each pair based on the
tertile of her co-twin. Each environmental factor and
genetic risk category (high and low) were entered into a
two-factor analysis of variance (with age-adjusted AI as the
dependent variable) to determine if there was a statistically
significant interaction between environmental factor and
genetic risk.
RESULTS
Mean age of the 684 subjects was 42.6 years (range 18 to 71
years). Of the 35% who were postmenopausal, 44% used
HRT. Of the subjects, 154 (23%) were current smokers and
144 (21%) ex-smokers. Body composition, hemodynamic,
and fasting biochemical variables are presented in Table 1.
Univariate analysis. As previously shown in this popula-
tion (9), AI was directly related to age and central mean
arterial pressure (CMAP), and inversely to heart rate in
unpaired analysis. Although AI was higher in postmeno-
pausal than premenopausal women (142  1% vs. 124 
1%, p  0.001), this was attenuated (p  0.18) after
adjusting for age. Triglyceride levels (r 0.1, p 0.03) and
apolipoprotein-B/A1 (r 0.1, p 0.04) were the only lipid
variables associated with AI after adjusting for age. There
were no relationships between AI and fasting levels of
glucose, insulin, HOMA-’, or HOMA-R’ (not shown).
Relationships between adiposity measures and AI are shown
in Table 2.
Lifestyle determinants of AI. Despite similar heart rate
and brachial BP, current smokers had higher AI than
Figure 1. Graphical representation of central arterial pressure waveform. P1 first systolic peak; P2 second systolic peak (systolic pressure); D diastolic
pressure; Augmentation index  (P2  D)/(P1  D)  100%.
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nonsmokers (134  2% vs. 129  1%, p  0.01). Never
smokers and ex-smokers had similar AI (129  1% vs. 130
 2%). Using abstainers as the reference group, subjects
drinking 16 to 20 (138  4%) U/week and 21 to 40 (137 
4%) U/week had higher AI than abstainers (125 3%, both
p  0.02). These differences remained statistically signifi-
cant after controlling for smoking. The 282 subjects who
participated in regular leisure-time physical activity had
similar AI to those who did not (p  0.32). There was no
relationship between duration of weekly activity and AI in
physically active subjects (not shown). Among postmeno-
pausal women, HRT users and nonusers had similar AI
(141  2 vs. 143  2). Although premenopausal women
taking the oral contraceptive pill (n  83) had lower AI
than those who did not (117  3 vs. 126  1, p  0.05),
there was no difference after adjusting for age (p  0.65).
Stepwise multiple regression analysis. In stepwise multi-
ple regression analysis, age, CMAP, heart rate, height,
percentage of CAF, and smoking explained 40% of the
variance in AI (Table 3). Apolipoprotein-B/A1, triglyceride
levels, and alcohol intake (15 vs. 15 U/week) were not
significant predictors of AI in this model.
Co-twin case-control (MZ twin) analysis. Co-twin case-
control analysis was performed in MZ twins to examine the
discrete contribution of total and central obesity, smoking,
and alcohol intake to AI independent of genetic effects.
Discordance for AI was defined as a within-pair difference
of 6%. Discordant twin pairs (n  37) had greater
within-pair differences in CAF (0.32  0.04 kg vs. 0.15 
0.03 kg, p  0.02) and percentage of CAF (5.9  0.8% vs.
2.8  0.7%, p  0.006) than concordant pairs (n  16).
Therefore, 170 g and 3.1% absolute within-pair differences
in CAF and percentage of CAF, respectively, accounted for
a 6% within-pair difference in AI. Twin pairs discordant
and concordant for TBF and percentage of TBF had similar
within-pair differences in AI (not shown). Therefore, our
data do not support any impact of TBF on AI after
controlling for genetic effects. There were no differences in
AI between twin pairs concordant and discordant for
smoking or heavy alcohol consumption (not shown).
Gene-environment interaction analysis. Gene-environment
interaction analysis was performed to investigate whether
relationships between AI and environmental factors were
modulated by genetic susceptibility to increased AI. No
gene-environment interactions were found with smoking,
alcohol consumption, or HRT. However, a significant
interaction between physical activity and genetic risk of
increased AI was found (p  0.01) (Fig. 2). In subjects at
high genetic risk of increased AI, participation in regular
leisure-time physical activity was associated with signifi-
cantly lower AI than nonparticipation (125  3% vs. 138 
3%, p 0.008). In contrast, in subjects at low genetic risk,
physically active and inactive subjects had similar AI (126
3% vs. 123  2%, p  0.46). This means that subjects
genetically predisposed to increased AI who participated in
regular physical activity had AI values equivalent to subjects
Table 1. Body Composition Data, Peripheral and Central
Hemodynamic Indexes, and Fasting Biochemical Parameters in
Healthy Female Twins
Variables Mean  SD
Age (yrs) 42.6  11.8
Weight (kg) 65.6  12
Body mass index (kg/m2) 24.7  4.4
Waist circumference (cm) 78.7  10.2
Total body fat (kg) 22.1  8.4
Total body fat (%) 32.7  7.4
Central abdominal fat (kg) 1.2  0.7
Central abdominal fat (%) 29.5  11.2
Lean body mass (kg) 38.8  5.1
Heart rate (beats/min) 74  11
BSBP (mm Hg) 119  17
BDBP (mm Hg) 75  11
CSBP (mm Hg) 109  16
CDBP (mm Hg) 77  12
CMAP (mm Hg) 92  13
Augmentation index (%) 131  24
Plasma glucose (mmol/l) 4.4  0.5
Plasma insulin (mIU/l) 6.4  3.6
Apolipoprotein-Al (g/l) 1.68  0.36
Apolipoprotein-B (g/l) 1.10  0.34
Apolipoprotein-B/A1 0.68  0.25
Total cholesterol level (mmol/l) 5.27  1.19
HDL-cholesterol level (mmol/l) 1.5  0.39
Triglyceride level (mmol/l) 1.07  0.53
n  684 except for fasting insulin (n  558) and lipid levels (n  579).
BDBP  brachial diastolic blood pressure; BSBP  brachial systolic blood
pressure; CDBP  central diastolic blood pressure; CSBP  central systolic blood
pressure; CMAP  central mean arterial pressure; HDL  high-density lipoprotein.
Table 2. Univariate Correlation Coefficients Between Age-
Adjusted Augmentation Index and Anthropometric and Direct
Measures of Total Body and Central Abdominal Adiposity in




(r Value) p Value
Weight (kg) 0.05 0.37
Height (m) 0.14 0.001
Body mass index (kg/m2) 0.10 0.016
Waist circumference (cm) 0.05 0.25
Total body fat (kg) 0.08 0.05
Total body fat (%) 0.11 0.006
Central abdominal fat (kg) 0.11 0.005
Central abdominal fat (%) 0.11 0.004
Lean body mass (kg) 0.01 0.57
Table 3. Independent Determinants of Augmentation Index in
Healthy Female Twins: Multiple Regression Analysis (n  681)
Independent Variables
Standardized
Coefficient () p Value
Age 0.31  0.001
CMAP 0.25  0.001
Heart rate 0.41  0.001
Height 0.16  0.001
Central abdominal fat (%) 0.08 0.02
Smoking 0.12  0.001
R2  0.4; p  0.001 for model using generalized estimating equation.
CMAP  central mean arterial pressure.
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at low genetic risk. When analysis of covariance was
performed in high genetic risk subjects, the difference in AI
remained significant when CMAP (p  0.02), heart rate (p
 0.002), height (p 0.02), percentage of CAF (p 0.02),
and smoking (p  0.03) were included as covariates.
Notably, there were no gene-environment interactions be-
tween smoking and genetic risk of systolic or diastolic
hypertension.
DISCUSSION
In 684 female twins, we examined the relationship between
AI and accurately measured hemodynamic, body composi-
tion, and environmental parameters. We specifically studied
twins to examine these relationships independent of genetic
effects and to evaluate any modulating effect of genetic
susceptibility. A major and novel finding of the current
study was that central abdominal adiposity was a significant
determinant of AI, independent of age, CMAP, heart rate,
height, smoking, and, in co-twin case-control analysis,
genetic factors. It is of some importance that 40% of the
variance in AI could be explained by age, CMAP, heart rate,
height, percentage of CAF, and smoking, as we have
previously shown the heritability of AI to be around 40%
(9). Another important finding was that regular physical
activity reduced the phenotypic expression of genetic sus-
ceptibility to increased AI; in gene-environment interaction
analysis, subjects at high genetic risk of increased AI who
participated in regular activity had similar AI values to
subjects at low genetic risk.
To our knowledge, no previous study has specifically
examined the relationship between central abdominal adi-
posity (measured by DXA) and AI in healthy pre- and
postmenopausal women. Previous reports concerning the
relationship between obesity and arterial stiffness have been
contradictory, related, in part, to the less accurate methods
used to measure body fat and its distribution. Studies have
reported disparate associations between AI and total adi-
posity estimated by weight, BMI, and hydrostatic weighing
(7,9,11,12,14,15,26). In relation to body fat distribution,
although surrogate estimates of abdominal fat have been
found to correlate directly with AI (14,15) and inversely
with arterial distensibility (27), the former were not signif-
icant after adjusting for age (15) and other AI determinants
(14). In studies in which abdominal fat was measured by
magnetic resonance imaging, despite no correlation with
anthropometric estimates or subcutaneous abdominal fat,
inverse relationships were found between visceral abdominal
fat and aortic (28) and carotid artery (29) distensibility, the
latter, however, explained by arterial diameter. Additionally,
recent experiments found that the reduction in AI induced
by infused insulin in normal individuals (30), although
impaired in insulin-resistant obese (31) and type 2 diabetic
subjects (32), is inversely related to total (15,31) and
abdominal obesity (15). Together with the current study,
these reports highlight the importance of body fat distribu-
tion in determining systemic arterial stiffness and offer a
potential mechanism linking these factors to adverse car-
diovascular outcomes.
Despite no overall relationship between leisure-time
physical activity and AI, we found that physically active
subjects at high genetic risk of increased AI had similar AI
to subjects at low genetic risk. In other words, the pheno-
typic expression of genetic susceptibility to increased AI was
reduced by regular physical activity. The reported effect of
physical activity on arterial stiffness and compliance is
inconsistent, related, in part, to differences between studies
in exercise regimens, measures of arterial stiffness and
compliance, cohort characteristics, and the completeness of
covariate adjustment (33–37). Using AI, it was reported that
endurance training partially protected against age-related
increases in arterial stiffness in men (12) and women (14). In
contrast, a recent study found that a three-month training
program had no effect on AI in postmenopausal women
(38). Our study raises the possibility that the relationship
between exercise and AI may depend on genetic risk. This
important protective effect on a known cardiac predictor
provides a further mechanism for understanding the bene-
ficial effect of physical activity on heart disease risk.
To our knowledge, this is the largest examination of the
relationship between chronic smoking and AI in healthy
pre- and postmenopausal women. Despite similar brachial
BP and HR, smokers had higher AI than nonsmokers, and
smoking was a significant independent determinant of AI in
multiple regression models. Our findings confirm some
(13,39–41), but not all (7), previous studies using AI.
Although the effect of smoking was not quantifiable in
co-twin case-control analysis, this may relate to small
numbers. We also found that ex-smokers had similar AI to
never smokers, implying that negative effects may be revers-
ible once smoking is ceased.
The finding that women drinking 15 U of alcohol per
Figure 2. Gene-environment interaction analysis: the association between
regular leisure-time physical activity and augmentation index in subjects at
low and high genetic risk of increased augmentation index. Open bars 
regular physical activity; hatched bars  no regular physical activity.
Data are mean  SEM. Interaction p  0.01. *p  0.008 compared to
subjects at high genetic risk not participating in regular physical activity.
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week had higher AI than abstainers contradicts a recent
report (42). In the current study, alcohol intake was not a
significant independent determinant of AI in multiple
regression analysis, and discordance in alcohol consumption
was not associated with greater differences in AI than
concordance in co-twin case-control analysis. Considering
epidemiologic evidence linking moderate alcohol consump-
tion to cardiovascular protection (43), an important negative
observation from the current analysis was that moderate
alcohol consumers had similar AI to abstainers.
We found no difference in AI between postmenopausal
women using and not using HRT, consistent with some
(44), but not all (26), previous cross-sectional studies. In a
randomized study of subjects with type 2 diabetes, we
reported no effect of HRT on AI, although half of these
subjects were hypertensive and already receiving vasodila-
tory therapy (45).
The main strength of this paper relates to the simulta-
neous accurate measurement of hemodynamic, metabolic,
and body composition parameters in a large cohort of
healthy pre- and postmenopausal females. The unique use
of the twin model extends previous epidemiologic studies by
allowing examination of associations between body fat and
AI independent of genetic influences and the modulating
effect of genetic susceptibility on these relationships. Lim-
itations include the study’s cross-sectional design, the self-
reported nature of lifestyle factors, and our inability to
control for dietary sodium intake, which has been shown to
influence AI (38). We are unable to comment on the
individual effects of estrogen and progesterone on AI. Our
results may not be applicable to non-Caucasian females,
males, or individuals with glucose intolerance or diabetes.
In conclusion, using accurate measures and the twin study
design, we investigated the relationship between AI and
metabolic, body fat, and lifestyle variables in female twins.
Central abdominal obesity was an important determinant of
AI, independent of age, CMAP, heart rate, height, smok-
ing, and, in co-twin case-control analysis, genetic effects. In
addition, smoking was independently associated with ele-
vated AI, while physical activity reduced the phenotypic
expression of genetic susceptibility to increased AI. Our
findings raise the possibility that AI is an intermediary
variable mediating the association between abdominal obe-
sity and cardiovascular morbidity and mortality and the
means by which smoking increases, and physical activity
decreases (particularly in genetically susceptible popula-
tions), coronary disease risk.
Acknowledgments
The authors thank Dr. Mathias Chiano for his assistance
and statistical advice. We are grateful to the twins from the
Twin Research and Genetic Epidemiology Unit, St.
Thomas’ Hospital, London, United Kingdom, for their
generous participation in this study.
Reprint requests and correspondence: Dr. Jerry R. Greenfield,
Department of Endocrinology, St. Vincent’s Hospital, Darlinghurst,
Sydney, NSW 2010, Australia. E-mail: j.greenfield@garvan.org.au.
REFERENCES
1. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safer
ME. Arterial wave reflections and survival in end-stage renal failure.
Hypertension 2001;38:434–8.
2. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an
independent predictor of all-cause and cardiovascular mortality in
hypertensive patients. Hypertension 2001;37:1236–41.
3. Nichols WW, Edwards DG. Arterial elastance and wave reflection
augmentation of systolic blood pressure: deleterious effects and impli-
cations for therapy. J Cardiovasc Pharmacol Ther 2001;6:5–21.
4. Kelly RP, Hayward C, Avolio A, O’Rourke MF. Noninvasive deter-
mination of age-related changes in the human arterial pulse. Circula-
tion 1989;80:1652–9.
5. Kelly RP, Hayward CS, Ganis J, Daley JM, Avolio A, O’Rourke MF.
Noninvasive registration of the arterial pressure pulse waveform using
high-fidelity applanation tonometry. J Vasc Med Biol 1989;1:142–9.
6. Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation
tonometry and a generalized transfer function to determine aortic
pressure augmentation in subjects with treated hypertension. J Am
Coll Cardiol 1998;32:1214–20.
7. Nu¨rnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR,
Philipp T, Schafers RF. Augmentation index is associated with
cardiovascular risk. J Hypertens 2002;20:2407–14.
8. Hayashi T, Nakayama Y, Tsumura K, Yoshimaru K, Ueda H.
Reflection in the arterial system and the risk of coronary heart disease.
Am J Hypertens 2002;15:405–9.
9. Snieder H, Hayward CS, Perks U, Kelly RP, Kelly PJ, Spector TD.
Heritability of central systolic pressure augmentation: a twin study.
Hypertension 2000;35:574–9.
10. North KE, MacCluer JW, Devereux RB, et al. Heritability of carotid
artery structure and function: the Strong Heart Family study. Arte-
rioscler Thromb Vasc Biol 2002;22:1698–703.
11. Hayward CS, Kelly RP. Gender-related differences in the central
arterial pressure waveform. J Am Coll Cardiol 1997;30:1863–71.
12. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic
capacity on arterial stiffness in healthy adults. Circulation 1993;88:
1456–62.
13. Brooks BA, Molyneaux LM, Yue DK. Augmentation of central
arterial pressure in type 2 diabetes. Diabet Med 2001;18:374–80.
14. Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in
central arterial stiffness in physically active women. Arterioscler
Thromb Vasc Biol 1998;18:127–32.
15. Westerbacka J, Seppala-Lindroos A, Yki-Ja¨rvinen H. Resistance to
acute insulin-induced decreases in large artery stiffness accompanies
the insulin resistance syndrome. J Clin Endocrinol Metab 2001;86:
5262–8.
16. Goldsmith HH. A zygosity questionnaire for young twins: a research
note. Behav Genet 1991;21:257–69.
17. Health Education Council and Sports Council. Allied Dunbar Na-
tional Fitness Survey. London: Belmont Press, 1992.
18. Samaras K, Kelly PJ, Chiano MN, Spector TD, Campbell LV.
Genetic and environmental influences on total-body and central
abdominal fat: the effect of physical activity in female twins. Ann
Intern Med 1999;130:873–82.
19. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of
endothelial function using peripheral waveform analysis: a clinical
application. J Am Coll Cardiol 2002;40:521–8.
20. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a
method for estimating ascending aortic pressure from the radial artery
pressure waveform. Hypertension 2001;38:932–7.
21. Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis of
the relationship between central aortic and peripheral upper limb
pressure waves in man. Eur Heart J 1993;14:160–7.
22. Jenkins AB, Samaras K, Carey DG, Kelly P, Campbell LV. Improved
indices of insulin resistance and insulin secretion for use in genetic and
population studies of type 2 diabetes mellitus. Twin Res 2000;3:148–
51.
269JACC Vol. 42, No. 2, 2003 Greenfield et al.
July 16, 2003:264–70 Determinants of AI in Female Twins
23. Middelberg RP, Spector TD, Swaminathan R, Snieder H. Genetic
and environmental influences on lipids, lipoproteins, and apolipopro-
teins: effects of menopause. Arterioscler Thromb Vasc Biol 2002;22:
1142–7.
24. Zhang Y, Glynn RJ, Felson DT. Musculoskeletal disease research:
should we analyze the joint or the person? J Rheumatol 1996;23:
1130–4.
25. Samaras K, Kelly PJ, Chiano MN, Arden N, Spector TD, Campbell
LV. Genes versus environment: the relationship between dietary fat
and total and central abdominal fat. Diabetes Care 1998;21:2069–76.
26. Hayward CS, Knight DC, Wren BG, Kelly RP. Effect of hormone
replacement therapy on non-invasive cardiovascular hemodynamics.
J Hypertens 1997;15:987–93.
27. van Popele NM, Westendorp IC, Bots ML, et al. Variables of the
insulin resistance syndrome are associated with reduced arterial dis-
tensibility in healthy non-diabetic middle-aged women. Diabetologia
2000;43:665–72.
28. Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL,
Soulen RL. Direct magnetic resonance determination of aortic disten-
sibility in essential hypertension: relation to age, abdominal visceral fat,
and in situ intracellular free magnesium. Hypertension 1997;30:
654–9.
29. Giltay EJ, Lambert J, Elbers JM, Gooren LJ, Asscheman H, Stehou-
wer CD. Arterial compliance and distensibility are modulated by body
composition in both men and women but by insulin sensitivity only in
women. Diabetologia 1999;42:214–21.
30. Westerbacka J, Wilkinson I, Cockcroft J, Utriainen T, Vehkavaara S,
Yki-Ja¨rvinen H. Diminished wave reflection in the aorta: a novel
physiological action of insulin on large blood vessels. Hypertension
1999;33:1118–22.
31. Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J,
Yki-Ja¨rvinen H. Marked resistance of the ability of insulin to decrease
arterial stiffness characterizes human obesity. Diabetes 1999;48:821–7.
32. Tamminen M,Westerbacka J, Vehkavaara S, Yki-Ja¨rvinen H. Insulin-
induced decreases in aortic wave reflection and central systolic pressure
are impaired in type 2 diabetes. Diabetes Care 2002;25:2314–9.
33. Kupari M, Hekali P, Keto P, Poutanen VP, Tikkanen MJ,
Standerstkjold-Nordenstam CG. Relation of aortic stiffness to factors
modifying the risk of atherosclerosis in healthy people. Arterioscler
Thromb 1994;14:386–94.
34. Mohiaddin RH, Underwood SR, Bogren HG, et al. Regional aortic
compliance studied by magnetic resonance imaging: the effects of age,
training, and coronary artery disease. Br Heart J 1989;62:90–6.
35. Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM.
Arterial compliance may influence baroreceptor function in athletes
and hypertensives. Am J Physiol 1995;268:H411–8.
36. Cameron JD, Dart AM. Exercise training increases total systemic
arterial compliance in humans. Am J Physiol 1994;266:H693–701.
37. Bertovic DA, Waddell TK, Gatzka CD, Cameron JD, Dart AM,
Kingwell BA. Muscular strength training is associated with low
arterial compliance and high pulse pressure. Hypertension 1999;33:
1385–91.
38. Seals DR, Tanaka H, Clevenger CM, et al. Blood pressure reductions
with exercise and sodium restriction in postmenopausal women with
elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol
2001;38:506–11.
39. Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure
and augmentation index in subjects with hypercholesterolemia. J Am
Coll Cardiol 2002;39:1005–11.
40. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse
pressure amplification. Hypertension 2003;41:183–7.
41. Fennessy F, Casey RG, Bouchier-Hayes D. Peripheral and central
arterial haemodynamic interactions are early abnormalities in young
male cigarette smokers. Eur J Vasc Endovasc Surg 2003;25:152–8.
42. Mahmud A, Feely J. Divergent effect of acute and chronic alcohol on
arterial stiffness. Am J Hypertens 2002;15:240–3.
43. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and
mortality among women. N Engl J Med 1995;332:1245–50.
44. Tanaka H, DeSouza CA, Seals DR. Arterial stiffness and hormone
replacement use in healthy postmenopausal women. J Gerontol A Biol
Sci Med Sci 1998;53:M344–6.
45. Hayward CS, Samaras K, Campbell L, Kelly RP. Effect of combina-
tion hormone replacement therapy on ambulatory blood pressure and
arterial stiffness in diabetic postmenopausal women. Am J Hypertens
2001;14:699–703.
270 Greenfield et al. JACC Vol. 42, No. 2, 2003
Determinants of AI in Female Twins July 16, 2003:264–70
